Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Mas

Showing results (91-100 of 215) with videos related to

Pageof 22
Sort By:
Plos One|June 5, 2014
External validation of the MRI-DRAGON score: early prediction of stroke outcome after intravenous thrombolysisGuillaume Turc, Pierre Aguettaz, Nelly Ponchelle-Dequatre, et al.
Stroke|September 22, 2012
Diffusion lesion reversal after thrombolysis: a MR correlate of early neurological improvementMarc-Antoine Labeyrie, Guillaume Turc, Agathe Hess, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|December 24, 2004
Comparison of cardiovascular risk factors and drug use in 14,544 French patients with a history of myocardial infarction, ischaemic stroke and/or peripheral arterial diseaseVanina Bongard, Jean-Pierre Cambou, Alain Lezorovcz, et al.
Stroke|November 22, 2008
The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registryChristian Weimar, Hans-Christoph Diener, Mark J Alberts, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 25, 2005
Antithrombotic management after an ischemic stroke in French primary care practice: results from three pooled cross-sectional studiesEmmanuel Touzé, Jean-Pierre Cambou, Jean Ferrières, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 31, 2011
Two-year vascular event rates in patients with symptomatic cerebrovascular disease: the REACH registryNarayanaswamy Venketasubramanian, Joachim Röther, Deepak L Bhatt, et al.
Journal of Neurology|March 18, 2018
Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic strokeSixtine Gilliot, Igor Sibon, Jean-Louis Mas, et al.
AJNR. American Journal of Neuroradiology|February 15, 2005
Spontaneous intracerebral hematoma on diffusion-weighted images: influence of T2-shine-through and T2-blackout effectsStéphane Silvera, Catherine Oppenheim, Emmanuel Touzé, et al.
Stroke|February 12, 2011
Restenosis is more frequent after carotid stenting than after endarterectomy: the EVA-3S studyCaroline Arquizan, Ludovic Trinquart, Pierre-Jean Touboul, et al.
European Journal of Preventive Cardiology|April 1, 2011
Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH RegistryJean Dallongeville, Deepak L Bhatt, P H Gabriel Steg, et al.
Pageof 22

Showing results (91-100 of 215) with videos related to

Sort By:
Pageof 22
Plos One|June 5, 2014
External validation of the MRI-DRAGON score: early prediction of stroke outcome after intravenous thrombolysisGuillaume Turc, Pierre Aguettaz, Nelly Ponchelle-Dequatre, et al.
Stroke|September 22, 2012
Diffusion lesion reversal after thrombolysis: a MR correlate of early neurological improvementMarc-Antoine Labeyrie, Guillaume Turc, Agathe Hess, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|December 24, 2004
Comparison of cardiovascular risk factors and drug use in 14,544 French patients with a history of myocardial infarction, ischaemic stroke and/or peripheral arterial diseaseVanina Bongard, Jean-Pierre Cambou, Alain Lezorovcz, et al.
Stroke|November 22, 2008
The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registryChristian Weimar, Hans-Christoph Diener, Mark J Alberts, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 25, 2005
Antithrombotic management after an ischemic stroke in French primary care practice: results from three pooled cross-sectional studiesEmmanuel Touzé, Jean-Pierre Cambou, Jean Ferrières, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 31, 2011
Two-year vascular event rates in patients with symptomatic cerebrovascular disease: the REACH registryNarayanaswamy Venketasubramanian, Joachim Röther, Deepak L Bhatt, et al.
Journal of Neurology|March 18, 2018
Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic strokeSixtine Gilliot, Igor Sibon, Jean-Louis Mas, et al.
AJNR. American Journal of Neuroradiology|February 15, 2005
Spontaneous intracerebral hematoma on diffusion-weighted images: influence of T2-shine-through and T2-blackout effectsStéphane Silvera, Catherine Oppenheim, Emmanuel Touzé, et al.
Stroke|February 12, 2011
Restenosis is more frequent after carotid stenting than after endarterectomy: the EVA-3S studyCaroline Arquizan, Ludovic Trinquart, Pierre-Jean Touboul, et al.
European Journal of Preventive Cardiology|April 1, 2011
Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH RegistryJean Dallongeville, Deepak L Bhatt, P H Gabriel Steg, et al.
Pageof 22